Rachana Mehul Shah
About Rachana Mehul Shah
Data last updated:
Rachana Mehul Shah is an Additional Director at Precise Biopharma Private Limited (since 2025), Director at Cyrus Remedies Private Limited (since 2024) and Additional Director at Solasta Laboratories Private Limited (since 2025), and holds 1 more current directorship. The companies operate in Pharma, Healthcare and Travel and Hospitality. The 2 current companies with reported revenue have a combined latest revenue of ₹209 Cr; the largest is Precise Biopharma Private Limited at ₹201 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Precise Biopharma Private Limited U24230MH2005PTC152453 | Additional Director | 20 Aug 2025 | 2005 | ₹201 Cr (FY 2025) | Active |
 Cyrus Remedies Private Limited U24110MH2021PTC365048 | Director | 15 Apr 2024 | 2021 | ₹8.41 Cr (FY 2024) | Active |
 Solasta Laboratories Private Limited U74999MH2018PTC304867 | Additional Director | 20 Aug 2025 | 2018 | Active | |
| Futzyme Biotech Private Limited U73100MH2022PTC383977 | Director | 02 Jun 2022 | 2022 | Active |
Board colleagues of Rachana Mehul Shah
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mehul Pravin Shah | 02657748 | Precise Biopharma Private Limited , Cyrus Remedies Private Limited and 2 more | Director |
| Sunil Sadanand Sukhathankar | 03148373 | Precise Biopharma Private Limited , Solasta Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rachana Mehul Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rachana Mehul Shah
Rachana Mehul Shah currently holds 4 directorships: Precise Biopharma Private Limited (Additional Director, since 20 Aug 2025, revenue ₹201 Cr (FY 2025)); Cyrus Remedies Private Limited (Director, since 15 Apr 2024, revenue ₹8.41 Cr (FY 2024)); Solasta Laboratories Private Limited (Additional Director, since 20 Aug 2025); Futzyme Biotech Private Limited (Director, since 02 Jun 2022).
Rachana Mehul Shah was first appointed on 02 Jun 2022 as Director at Futzyme Biotech Private Limited. The most recent appointment on record is 20 Aug 2025 at Solasta Laboratories Private Limited.
The 2 current companies of Rachana Mehul Shah that report revenue have a combined latest revenue of ₹209 Cr: Precise Biopharma Private Limited ₹201 Cr (FY 2025); Cyrus Remedies Private Limited ₹8.41 Cr (FY 2024).
The current boards of Rachana Mehul Shah's companies include Mehul Pravin Shah (Precise Biopharma Private Limited), Sunil Sadanand Sukhathankar (Precise Biopharma Private Limited).